These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21431640)

  • 41. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
    Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
    Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
    Charles KS; Winfield DA; Angel C; Goepel J
    Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
    Schilling G; Dierlamm J; Hossfeld DK
    Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of chromosome abnormalities using cytoplasmic immunoglobulin staining and FISH in myeloma.
    Mercer BR; Rayeroux KC
    Methods Mol Biol; 2011; 730():159-71. PubMed ID: 21431641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis.
    Hardan I; Rothman R; Gelibter A; Cohen N; Shimoni A; Sokolovsky M; Reichart M; Ishoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
    Exp Hematol; 2004 Mar; 32(3):254-60. PubMed ID: 15003310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of cytogenetic abnormalities with gene expression profiles.
    Zhou Y; Zhang Q; Stephens O; Heuck CJ; Tian E; Sawyer JR; Cartron-Mizeracki MA; Qu P; Keller J; Epstein J; Barlogie B; Shaughnessy JD
    Blood; 2012 May; 119(21):e148-50. PubMed ID: 22496154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses.
    de Haart SJ; Willems SM; Mutis T; Koudijs MJ; van Blokland MT; Lokhorst HM; de Weger RA; Minnema MC
    Blood Cancer J; 2016 May; 6(5):e426. PubMed ID: 27206246
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Daudignon A; Quilichini B; Ameye G; Poirel H; Bastard C; Terré C
    Ann Biol Clin (Paris); 2016 Oct; 74(5):588-595. PubMed ID: 27707673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytogenetics of solid tumours.
    Lukeis R; Suter M
    Methods Mol Biol; 2011; 730():173-87. PubMed ID: 21431642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of cytogenetic specimens from tissue samples.
    Bayani J; Squire JA
    Curr Protoc Cell Biol; 2004 Sep; Chapter 22():Unit 22.2. PubMed ID: 18228453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metaphase harvest and cytogenetic analysis of malignant hematological specimens.
    Dal Cin P
    Curr Protoc Hum Genet; 2003 May; Chapter 10():Unit 10.2. PubMed ID: 18428341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation, culture, and analysis of amniotic fluid samples.
    Meron PM
    Curr Protoc Hum Genet; 2001 May; Chapter 8():Unit 8.4. PubMed ID: 18428314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and culture of products of conception and other solid tissues for chromosome analysis.
    Warburton D
    Curr Protoc Hum Genet; 2001 May; Chapter 8():Unit 8.5. PubMed ID: 18428315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome Preparation for Myeloid Malignancies.
    Hui EK; Wan TS; Ng MH
    Methods Mol Biol; 2017; 1541():11-17. PubMed ID: 27910010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and culture of products of conception and other solid tissues for chromosome analysis.
    Levy B; Jobanputra V; Warburton D
    Curr Protoc Hum Genet; 2009 Jan; Chapter 8():Unit 8.5. PubMed ID: 19170032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interpretation of cytogenetic results in multiple myeloma for clinical practice.
    Rajan AM; Rajkumar SV
    Blood Cancer J; 2015 Oct; 5(10):e365. PubMed ID: 26517360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of direct harvest and cultures for karyotyping EDTA anticoagulated marrow.
    Houston EW; Riddle CE; Weiss GB; Gardner FH
    Cancer Genet Cytogenet; 1981 Aug; 4(1):61-7. PubMed ID: 6793228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New mitogens in cultures for multiple myeloma cytogenetic analysis.
    López de Frutos L; Álvarez Y; Armengol G; Caballín MR
    Leuk Lymphoma; 2013 Nov; 54(11):2548-50. PubMed ID: 23418873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.